Percutaneous Pulmonary Valve Implantation Based on Minimally Invasive Direct Coronary Bypass Surgery

Ann Thorac Surg. 2020 Oct;110(4):e323-e325. doi: 10.1016/j.athoracsur.2020.01.062. Epub 2020 Mar 4.

Abstract

Approximately 5% of percutaneous pulmonary valve implantations (PPVIs) are at risk for coronary compression. Therefore, PPVI is contraindicated if coronary anomalies and tested coronary flow impairment are observed. Simultaneous right ventricular outflow tract ballooning and coronary angiography are mandatory elucidating contraindications for PPVI. We present the case of a 22-year-old woman who had Rastelli repair with chronic right heart failure. Weighing the risk of several offered surgical options, she underwent successful PPVI after minimally invasive direct coronary artery bypass procedure.

Publication types

  • Case Reports

MeSH terms

  • Contraindications, Procedure
  • Coronary Artery Bypass / methods*
  • Female
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valve Prosthesis Implantation / methods*
  • Humans
  • Minimally Invasive Surgical Procedures
  • Pulmonary Valve / surgery*
  • Pulmonary Valve Stenosis / surgery*
  • Young Adult